﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/merck-to-acquire-us-biopharma-firm-springworks-therapeutics-for-enterprise-value-of-34-billion-17078</loc><lastmod>2025-04-28T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/biocon-biologics-receives-positive-chmp-opinions-for-biosimilar-denosumab-in-europe-17079</loc><lastmod>2025-04-28T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/curateq-biologics-receives-positive-opinion-for-biosimilar-dazublys-from-ema-17080</loc><lastmod>2025-04-28T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/dr-lal-path-labs-posts-q4-fy25-consolidated-pat-at-rs-1548-cr-17081</loc><lastmod>2025-04-28T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>